By Torbjörn Blank, Product Manager, and Mikael Björling, Automation Engineer, Cytiva
Automation will drive optimization and connectedness throughout development and manufacturing, playing an essential role in the future of biopharma. Future-proofing your facility by implementing automated technologies that enable scale-up can enhance consistency and reliability and improve the quality of your drug product.
However, there is a growing trend with drug manufacturers implementing full-scale automation to leave critical decisions about the system's and facility's key functionality to the engineering company configuring the distributed control system (DCS). Without bioprocessing knowledge, a third-party integrator could create a system that won't work in the best way.
Cytiva has developed ÄKTA process DCS, a turnkey solution that combines proven industrial automation with a high-quality chromatography system. The system comes with a predefined automation software solution that applies Cytiva’s process and equipment expertise to Emerson’s DeltaV™ DCS platform.
With the ÄKTA process DCS, Cytiva’s automation experts collaborate with in-house application and process specialists to ensure they understand your needs and build a system with the critical functionality needed for every step in your process.